Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus

By sjmartinez • March 15, 2025

Zhang Y, Tedeschi SK, Abhishek A, Hensey O, Grossberg D, Cai K, Shea B, Singh JA, Christensen R, Serban T, Cipolletta E, Parperis K, Diaz-Torne C, McCarthy GM, Becce F, Gheita TA, Sirotti S, Christiansen SN, Coronel L, Stamp LK, Abdel-Fattah YH, Pascart T, Filippou G, Hong LE, FitzGerald J, Dalbeth N. Core domain set for chronic and/or recurrent manifestations of calcium pyrophosphate deposition disease: OMERACT delphi survey to establish consensus. Semin Arthritis Rheum. 2025 Mar 7;72:152669. doi: 10.1016/j.semarthrit.2025.152669. Epub ahead of print. PMID: 40086154.

Tags: calcium pyrophosphate deposition disease, Core domain set, Delphi, Domain, OMERACT, Publications, Rheumatology, Veterans Administration

Related Posts

Perceived Utility of Cognitive Behavioral Therapy in People With Bowel Disorders of Gut-Brain Interaction

Veraza DI, Waseem MR, Venezia J, Montero AM, Jones S, Kadariya J, Gupta A, Xu H, Shin A. Perceived Utility of Cognitive Behavioral Therapy in[...]

Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections

Mackow NA, Shao W, Ge L, Komarow L, Jiang J, Boutzoukas A, Chen L, Garcia-Diaz J, Herc ES, Doi Y, Arias CA, Albin O, Saade[...]

Target-Dose Versus Below-Target-Dose ACE Inhibitors and Lower Risk of Kidney Failure in U.S. Veterans with HFrEF

Ahmed AA, Lu F, Zhang S, Raman VK, Patel SS, Morgan CJ, Faselis C, Lam PH, Fonarow GC, Heidenreich PA, Ahmad T, Anker SD, Metra[...]